Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

Summary

The aim of this study was to document the immunogenicity and safety of a booster dose of IMOJEV administered at least 12 months after the primary dose. Primary objective: * To describe the immune response to Japanese Encephalitis (JE) before and 28 days after a booster dose of IMOJEV administered at least 12 months after primary vaccination with IMOJEV. Exploratory objectives: * To describe the safety profile of a booster dose of IMOJEV® .

Timeline

Start

2013-07-11

Primary completion

2014-03-11

Completion

2014-03-11

Drugs

Indications